U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Khunti K, Griffin S, Brennan A, et al. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT. Southampton (UK): NIHR Journals Library; 2021 Dec. (Health Technology Assessment, No. 25.77.)

Cover of Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT

Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.

Show details

References

1.
Yates T, Griffin S, Bodicoat DH, Brierly G, Dallosso H, Davies MJ, et al. PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial. Trials 2015;16:289. 10.1186/s13063-015-0813-z [PMC free article: PMC4488033] [PubMed: 26130075] [CrossRef]
2.
IDF Diabetes Atlas. 5th edn. Brussels: International Diabetes Federation, Executive Office; 2011.
3.
Leung MY, Pollack LM, Colditz GA, Change SH. Life years lost and lifetime health care expenditures associated with diabetes in the United States. Value Health 2014;17:A245–6. 10.1016/j.jval.2014.03.1433 [CrossRef]
4.
Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012;29:855–62. 10.1111/j.1464-5491.2012.03698.x [PubMed: 22537247] [CrossRef]
5.
World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. Geneva: World Health Organization; 2006.
6.
National Institute for Health and Care Excellence (NICE). Preventing Type 2 Diabetes: Risk Identification and Interventions for Individuals at High Risk. NICE Guidelines PH38 . London: NICE; 2012.
7.
International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34. 10.2337/dc09-9033 [PMC free article: PMC2699715] [PubMed: 19502545] [CrossRef]
8.
Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279–90. 10.1016/S0140-6736(12)60283-9 [PMC free article: PMC3891203] [PubMed: 22683128] [CrossRef]
9.
Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334:299. 10.1136/bmj.39063.689375.55 [PMC free article: PMC1796695] [PubMed: 17237299] [CrossRef]
10.
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783–9. 10.1016/S0140-6736(08)60766-7 [PubMed: 18502303] [CrossRef]
11.
Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677–86. 10.1016/S0140-6736(09)61457-4 [PMC free article: PMC3135022] [PubMed: 19878986] [CrossRef]
12.
Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673–9. 10.1016/S0140-6736(06)69701-8 [PubMed: 17098085] [CrossRef]
13.
Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008;336:1180–5. 10.1136/bmj.39545.585289.25 [PMC free article: PMC2394709] [PubMed: 18426840] [CrossRef]
14.
Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, Khunti K. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 2014;37:922–33. 10.2337/dc13-2195 [PubMed: 24652723] [CrossRef]
15.
Galaviz KI, Weber MB, Straus A, Haw JS, Narayan KMV, Ali MK. Global diabetes prevention interventions: a systematic review and network meta-analysis of the real-world impact on incidence, weight, and glucose. Diabetes Care 2018;41:1526–34. 10.2337/dc17-2222 [PMC free article: PMC6463613] [PubMed: 29934481] [CrossRef]
16.
Valabhji J, Barron E, Bradley D, Bakhai C, Fagg J, O’Neill S, et al. Early outcomes from the English National Health Service Diabetes Prevention Program. Diabetes Care 2020;43:152–60. 10.2337/dc19-1425 [PMC free article: PMC7115827] [PubMed: 31719054] [CrossRef]
17.
Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol 2005;99:1193–204. 10.1152/japplphysiol.00160.2005 [PubMed: 16103522] [CrossRef]
18.
Jeon CY, Lokken RP, Hu FB, van Dam RM. Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care 2007;30:744–52. 10.2337/dc06-1842 [PubMed: 17327354] [CrossRef]
19.
Laaksonen DE, Lindström J, Lakka TA, Eriksson JG, Niskanen L, Wikström K, et al. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005;54:158–65. 10.2337/diabetes.54.1.158 [PubMed: 15616024] [CrossRef]
20.
Yates T, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, et al. Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. Lancet 2014;383:1059–66. 10.1016/S0140-6736(13)62061-9 [PubMed: 24361242] [CrossRef]
21.
McCarthy M, Edwardson CL, Davies MJ, Henson J, Gray L, Khunti K, Yates T. Change in sedentary time, physical activity, bodyweight, and Hba1c in high-risk adults. Med Sci Sports Exerc 2017;49:1120–5. 10.1249/MSS.0000000000001218 [PMC free article: PMC5426555] [PubMed: 28121795] [CrossRef]
22.
Yates T, Khunti K, Bull F, Gorely T, Davies MJ. The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia 2007;50:1116–26. 10.1007/s00125-007-0638-8 [PMC free article: PMC1871609] [PubMed: 17415549] [CrossRef]
23.
National Institute for Health and Care Excellence (NICE). Guidance on the Use of Patient-Education Models for Diabetes. Technology appraisal 60. London: NICE; 2003.
24.
Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ 2008;336:491–5. 10.1136/bmj.39474.922025.BE [PMC free article: PMC2258400] [PubMed: 18276664] [CrossRef]
25.
Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, et al. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ 2010;341:c4093. 10.1136/bmj.c4093 [PMC free article: PMC2924963] [PubMed: 20729270] [CrossRef]
26.
Gray LJ, Khunti K, Williams S, Goldby S, Troughton J, Yates T, et al. Let’s prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation. Cardiovasc Diabetol 2012;11:56. 10.1186/1475-2840-11-56 [PMC free article: PMC3431251] [PubMed: 22607160] [CrossRef]
27.
Yates T, Davies M, Gorely T, Bull F, Khunti K. Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care 2009;32:1404–10. 10.2337/dc09-0130 [PMC free article: PMC2713638] [PubMed: 19602539] [CrossRef]
28.
Yates T, Edwardson CL, Henson J, Gray LJ, Ashra NB, Troughton J, et al. Walking Away from Type 2 diabetes: a cluster randomized controlled trial. Diabet Med 2017;34:698–707. 10.1111/dme.13254 [PubMed: 27589017] [CrossRef]
29.
Naughton F, Jamison J, Boase S, Sloan M, Gilbert H, Prevost AT, et al. Randomized controlled trial to assess the short-term effectiveness of tailored web- and text- based facilitation of smoking cessation in primary care (iQuit in Practice). Addiction 2014;109:1184–93. 10.1111/add.12556 [PMC free article: PMC4309513] [PubMed: 24661312] [CrossRef]
30.
Lin PH, Wang Y, Levine E, Askew S, Lin S, Chang C, et al. A text messaging-assisted randomized lifestyle weight loss clinical trial among overweight adults in Beijing. Obesity 2014;22:E29–37. 10.1002/oby.20686 [PubMed: 24375969] [CrossRef]
31.
Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 2013;1:191–8. 10.1016/S2213-8587(13)70067-6 [PubMed: 24622367] [CrossRef]
32.
Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLOS ONE 2014;9:e114268. 10.1371/journal.pone.0114268 [PMC free article: PMC4257733] [PubMed: 25479285] [CrossRef]
33.
Chakranon P, Lai YK, Tang YW, Choudhary P, Khunti K, Lee SWH. Distal technology interventions in people with diabetes: an umbrella review of multiple health outcomes. Diabet Med 2020;37:1966–76. 10.1111/dme.14156 [PubMed: 31631398] [CrossRef]
34.
Vodopivec-Jamsek V, de Jongh T, Gurol-Urganci I, Atun R, Car J. Mobile phone messaging for preventive health care. Cochrane Database Syst Rev 2012;12:. 10.1002/14651858.CD007457.pub2 CD007457 [PMC free article: PMC6486007] [PubMed: 23235643] [CrossRef]
35.
Baskerville R, Ricci-Cabello I, Roberts N, Farmer A. Impact of accelerometer and pedometer use on physical activity and glycaemic control in people with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2017;34:612–20. 10.1111/dme.13331 [PubMed: 28173623] [CrossRef]
36.
Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007;298:2296–304. 10.1001/jama.298.19.2296 [PubMed: 18029834] [CrossRef]
37.
Barnett AH, Dixon AN, Bellary S, Hanif MW, O’hare JP, Raymond NT, Kumar S. Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia 2006;49:2234–46. 10.1007/s00125-006-0325-1 [PubMed: 16847701] [CrossRef]
38.
Fischbacher CM, Hunt S, Alexander L. How physically active are South Asians in the United Kingdom? A literature review. J Public Health 2004;26:250–8. 10.1093/pubmed/fdh158 [PubMed: 15454592] [CrossRef]
39.
Yates T, Davies MJ, Gray LJ, Webb D, Henson J, Gill JM, et al. Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes. Prev Med 2010;51:290–4. 10.1016/j.ypmed.2010.06.011 [PubMed: 20600259] [CrossRef]
40.
Ghouri N, Purves D, McConnachie A, Wilson J, Gill JM, Sattar N. Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-aged South Asian compared with European men living in the UK. Diabetologia 2013;56:2238–49. 10.1007/s00125-013-2969-y [PMC free article: PMC3764328] [PubMed: 23811809] [CrossRef]
41.
Williams ED, Stamatakis E, Chandola T, Hamer M. Physical activity behaviour and coronary heart disease mortality among South Asian people in the UK: an observational longitudinal study. Heart 2011;97:655–9. 10.1136/hrt.2010.201012 [PubMed: 21131381] [CrossRef]
42.
Bhopal RS, Douglas A, Wallia S, Forbes JF, Lean ME, Gill JM, et al. Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet Diabetes Endocrinol 2014;2:218–27. 10.1016/S2213-8587(13)70204-3 [PubMed: 24622752] [CrossRef]
43.
Gillett M, Brennan A, Watson P, Khunti K, Davies M, Mostafa S, Gray LJ. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study. Health Technol Assess 2015;19(33). [PMC free article: PMC4780875] [PubMed: 25947106]
44.
Gray LJ, Davies MJ, Hiles S, Taub NA, Webb DR, Srinivasan BT, Khunti K. Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 2012;55:959–66. 10.1007/s00125-011-2432-x [PubMed: 22231125] [CrossRef]
45.
Medical Research Council Epidemiology Unit, University of Cambridge. Fenland Study: Information for Researchers. URL: www​.mrc-epid.cam.ac.uk​/research/studies/fenland​/information-for-researchers/ (accessed 19 November 2021).
46.
Leicester City Council. Diversity and Migration: Community Insights Including Facts from Census 2011. Leicester: Leicester City Council; 2012.
47.
World Health Organization. Use of Glycatedhaemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation. 2011. URL: www​.who.int/diabetes​/publications/diagnosis_diabetes2011/en/ (accessed 2 August 2016). [PubMed: 26158184]
48.
National Institute for Health and Care Excellence (NICE). Type 2 Diabetes: Prevention in People at High Risk. London: NICE; 2012.
49.
Leventhal H, Meyer D, Nerenz D. The Common Sense Representation of Illness Danger. In Rachman S, editor. Contributions to Medical Psychology. New York, NY: Pergamon Press; 1980. pp. 7–30.
50.
Tudor-Locke C, Johnson WD, Katzmarzyk PT. Accelerometer-determined steps per day in US adults. Med Sci Sports Exerc 2009;41:1384–91. 10.1249/MSS.0b013e318199885c [PubMed: 19516163] [CrossRef]
51.
Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 1998;30:777–81. 10.1097/00005768-199805000-00021 [PubMed: 9588623] [CrossRef]
52.
UK Chief Medical Officer (CMO) Guidelines Writing Group. UK Chief Medical Officers’ Physical Activity Guidelines. 2019. URL: https://assets​.publishing​.service.gov.uk​/government/uploads/system​/uploads/attachment_data​/file/832868​/uk-chief-medical-officers-physical-activity-guidelines​.pdf (accessed 17 November 2021).
53.
Besson H, Brage S, Jakes RW, Ekelund U, Wareham NJ. Estimating physical activity energy expenditure, sedentary time, and physical activity intensity by self-report in adults. Am J Clin Nutr 2010;91:106–14. 10.3945/ajcn.2009.28432 [PubMed: 19889820] [CrossRef]
54.
D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743–53. 10.1161/CIRCULATIONAHA.107.699579 [PubMed: 18212285] [CrossRef]
55.
Gopal DP, Usher-Smith JA. Cardiovascular risk models for South Asian populations: a systematic review. Int J Public Health 2016;61:525–34. 10.1007/s00038-015-0733-4 [PubMed: 26361963] [CrossRef]
56.
Panter J, Jones AP, van Sluijs EMF, Griffin SJ, Wareham NJ. Environmental and psychological correlates of older adult’s active commuting. Med Sci Sports Exerc 2011;43:1235–43. 10.1249/MSS.0b013e3182078532 [PMC free article: PMC3842528] [PubMed: 21131863] [CrossRef]
57.
McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, et al. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010;362:1477–90. 10.1056/NEJMoa1001121 [PubMed: 20228403] [CrossRef]
58.
Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998;316:736–41. 10.1136/bmj.316.7133.736 [PMC free article: PMC28477] [PubMed: 9529408] [CrossRef]
59.
Ware JE, GlaxoSmithKline. How to Score and Interpret Single-item Health Status Measures: A Manual for Users of the SF-8 Health Survey: (With a Supplement on the SF-6 Health Survey). Lincoln, RI: QualityMetric, Inc.; 2001.
60.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70. 10.1111/j.1600-0447.1983.tb09716.x [PubMed: 6880820] [CrossRef]
61.
Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res 2006;60:631–7. 10.1016/j.jpsychores.2005.10.020 [PubMed: 16731240] [CrossRef]
62.
Sniehotta FF, Nagy G, Scholz U, Schwarzer R. The role of action control in implementing intentions during the first weeks of behaviour change. Br J Social Psychol 2006;45:87–106. 10.1348/014466605X62460 [PubMed: 16573874] [CrossRef]
63.
Tudor-Locke C, Bassett DR Jr. How many steps/day are enough? Sports Med 2004;34:1–8. 10.2165/00007256-200434010-00001 [PubMed: 14715035] [CrossRef]
64.
Chan CB, Ryan DA, Tudor-Locke C. Health benefits of a pedometer-based physical activity intervention in sedentary workers. Prev Med 2004;39:1215–22. 10.1016/j.ypmed.2004.04.053 [PubMed: 15539058] [CrossRef]
65.
Merom D, Rissel C, Phongsavan P, Smith BJ, Van Kemenade C, Brown WJ, Bauman AE. Promoting walking with pedometers in the community: the step-by-step trial. Am J Prev Med 2007;32:290–7. 10.1016/j.amepre.2006.12.007 [PubMed: 17303369] [CrossRef]
66.
Yates T, Gray LJ, Henson J, Edwardson CL, Khunti K, Davies MJ. Impact of depression and anxiety on change to physical activity following a pragmatic diabetes prevention program within primary care: pooled analysis from two randomized controlled trials. Diabetes Care 2019;42:1847–53. 10.2337/dc19-0400 [PubMed: 31399440] [CrossRef]
67.
Ekelund U, Tarp J, Steene-Johannessen J, Hansen BH, Jefferis B, Fagerland MW, et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis. BMJ 2019;366:l4570. 10.1136/bmj.l4570 [PMC free article: PMC6699591] [PubMed: 31434697] [CrossRef]
68.
Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess 2005;128:1–11. [PMC free article: PMC4780988] [PubMed: 16194123]
69.
White IR, Carpenter J, Horton NJ. Including all individuals is not enough: lessons for intention-to-treat analysis. Clin Trials 2012;9:396–407. 10.1177/1740774512450098 [PMC free article: PMC3428470] [PubMed: 22752633] [CrossRef]
70.
Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, et al. SPHR Diabetes Prevention Model: Detailed Description of Model Background, Methods, Assumptions and Parameters. Sheffield: School of Health and Related Research, University of Sheffield; 2015.
71.
NHS Improvement. Reference Costs. URL: www​.england.nhs.uk/national-cost-collection/ (accessed November 2021).
72.
Curtis LA, Burns A. Unit Costs of Health and Social Care 2018. Canterbury: Personal Social Services Research Unit, University of Kent; 2018.
73.
Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle PJ, et al. The impact of Type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. Diabet Med 2017;34:632–40. 10.1111/dme.13314 [PubMed: 28075544] [CrossRef]
74.
NHS Digital. Health Survey for England 2014. Leeds: NHS Digital; 2015.
75.
National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology Appraisal 2013. London: NICE; 2013. [PubMed: 27905712]
76.
Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health 2015;18:161–72. 10.1016/j.jval.2015.02.001 [PubMed: 25773551] [CrossRef]
77.
Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. URL: www​.medicinescomplete.com (accessed 17 December 2019).
78.
Department of Health and Social Care. NHS Reference Costs. URL: www​.england.nhs.uk/national-cost-collection/ (accessed 17 December 2019).
79.
Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: results from a UK general population survey. Working Papers. York: Centre for Health Economics, University of York; 1995.
80.
Yates T, Davies MJ, Henson J, Troughton J, Edwardson C, Gray LJ, Khunti K. Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Fam Pract 2012;13:46. 10.1186/1471-2296-13-46 [PMC free article: PMC3444401] [PubMed: 22642610] [CrossRef]
81.
Bandura A. Social Foundations of Thought and Action. Englewood Cliffs, NJ: Pearson; 1986.
82.
Gollwitzer PM. Implementation intentions: strong effects of simple plans. Am Psychol 1999;54:493. 10.1037/0003-066X.54.7.493 [CrossRef]
83.
Leventhal H, Meyer D, Nerenz DR. The common sense representation of illness danger. Contributions to Medical Psychology 1980;2:7–30.
84.
Chaiken S. The Heuristic Model of Persuasion. In Zanna MP, Olson JM, Herman CP, editors. Social Influence: The Ontario Symposium, Volume 5. Hillsdale, NJ: Lawrence Erlbaum; 1987. pp. 2–29.
85.
Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French DP. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy. Psychol Health 2011;26:1479–98. 10.1080/08870446.2010.540664 [PubMed: 21678185] [CrossRef]
86.
National Institute for Health and Care Excellence (NICE). Preventing Type 2 Diabetes: Population and Community-level Interventions. London: NICE; 2012.
87.
Fonteyn ME, Kuipers B, Grobe SJ. A description of think aloud method and protocol analysis. Qual Health Res 1993;3:430–41. 10.1177/104973239300300403 [CrossRef]
88.
Abras C, Maloney-Krichmar D, Preece J. User-centered Design. Bainbridge W. Encyclopedia of Human-Computer Interaction. Thousand Oaks, CA: SAGE Publications Ltd; 2004. pp. 445–56.
89.
Dijkstra A, De Vries H. The development of computer-generated tailored interventions. Patient Educ Couns 1999;36:193–203. 10.1016/S0738-3991(98)00135-9 [PubMed: 10223023] [CrossRef]
90.
Whittaker R, Merry S, Dorey E, Maddison R. A development and evaluation process for mHealth interventions: examples from New Zealand. J Health Commun 2012;17:11–21. 10.1080/10810730.2011.649103 [PubMed: 22548594] [CrossRef]
91.
Fjeldsoe BS, Miller YD, O’Brien JL, Marshall AL. Iterative development of MobileMums: a physical activity intervention for women with young children. Int J Behav Nutr Phys Act 2012;9:151. 10.1186/1479-5868-9-151 [PMC free article: PMC3541201] [PubMed: 23256730] [CrossRef]
92.
Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013;46:81–95. 10.1007/s12160-013-9486-6 [PubMed: 23512568] [CrossRef]
93.
Fanning J, Mullen SP, McAuley E. Increasing physical activity with mobile devices: a meta-analysis. J Med Internet Res 2012;14:e161. 10.2196/jmir.2171 [PMC free article: PMC3514847] [PubMed: 23171838] [CrossRef]
94.
Nguyen HQ, Gill DP, Wolpin S, Steele BG, Benditt JO. Pilot study of a cell phone-based exercise persistence intervention post-rehabilitation for COPD. Int J Chron Obstruct Pulmon Dis 2009;4:301–13. 10.2147/COPD.S6643 [PMC free article: PMC2740952] [PubMed: 19750190] [CrossRef]
95.
Hurling R, Catt M, Boni MD, Fairley BW, Hurst T, Murray P, et al. Using internet and mobile phone technology to deliver an automated physical activity program: randomized controlled trial. J Med Internet Res 2007;9:e7. 10.2196/jmir.9.2.e7 [PMC free article: PMC1874722] [PubMed: 17478409] [CrossRef]
96.
Head KJ, Noar SM, Iannarino NT, Grant Harrington N. Efficacy of text messaging-based interventions for health promotion: a meta-analysis. Soc Sci Med 2013;97:41–8. 10.1016/j.socscimed.2013.08.003 [PubMed: 24161087] [CrossRef]
97.
Newton KH, Wiltshire EJ, Elley CR. Pedometers and text messaging to increase physical activity: randomized controlled trial of adolescents with type 1 diabetes. Diabetes Care 2009;32:813–15. 10.2337/dc08-1974 [PMC free article: PMC2671105] [PubMed: 19228863] [CrossRef]
98.
Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychol 2009;28:690–701. 10.1037/a0016136 [PubMed: 19916637] [CrossRef]
99.
Carver CS, Scheier MF. On the Self-regulation of Behavior. Cambridge: Cambridge University Press; 2001.
100.
Morton K, Sutton S, Hardeman W, Troughton J, Yates T, Griffin S, et al. A text-messaging and pedometer program to promote physical activity in people at high risk of type 2 diabetes: the development of the PROPELS follow-on support program. JMIR Mhealth Uhealth 2015;3:e105. 10.2196/mhealth.5026 [PMC free article: PMC4704921] [PubMed: 26678750] [CrossRef]
101.
Avery L, Flynn D, van Wersch A, Sniehotta FF, Trenell MI. Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions. Diabetes Care 2012;35:2681–9. 10.2337/dc11-2452 [PMC free article: PMC3507564] [PubMed: 23173137] [CrossRef]
102.
Hankonen N, Sutton S, Prevost AT, Simmons RK, Griffin SJ, Kinmonth AL, Hardeman W. Which behavior change techniques are associated with changes in physical activity, diet and body mass index in people with recently diagnosed diabetes? Ann Behav Med 2014;49:7–17. 10.1007/s12160-014-9624-9 [PMC free article: PMC4335098] [PubMed: 24806469] [CrossRef]
103.
Hagger M, Chatzisarantis NLD, Biddle SJH. A meta-analytic review of the theories of reasoned action and planned behavior in physical activity: predictive validity and the contribution of additional variables. J Sport Exercise Psychol 2002;24:3–32. 10.1123/jsep.24.1.3 [CrossRef]
104.
Vallerand RJ. A Hierarchical Model of Intrinsic and Extrinsic Motivation for Sport and Physical Activity. In Hagger MS, Chatzisarantis NLD, editors. Intrinsic Motivation and Self-determination in Exercise and Sport. Washington, DC: American Psychological Association; 2007. pp. 255–79. 10.5040/9781718206632.ch-017 [CrossRef]
105.
Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977;84:191–215. 10.1037//0033-295x.84.2.191 [PubMed: 847061] [CrossRef]
106.
Anderson ES, Wojcik JR, Winett RA, Williams DM. Social-cognitive determinants of physical activity: the influence of social support, self-efficacy, outcome expectations, and self-regulation among participants in a church-based health promotion study. Health Psychol 2006;25:510–20. 10.1037/0278-6133.25.4.510 [PubMed: 16846326] [CrossRef]
107.
Charmaz K. Constructing Grounded Theory. Thousand Oaks, CA: SAGE Publications Ltd; 2014.
108.
Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Tudor-Locke C, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc 2011;43:1575–81. 10.1249/MSS.0b013e31821ece12 [PubMed: 21681120] [CrossRef]
109.
Skinner TC, Carey ME, Cradock S, Dallosso HM, Daly H, Davies MJ, et al. ‘Educator talk’ and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomized controlled trial. Diabet Med 2008;25:1117–20. 10.1111/j.1464-5491.2008.02492.x [PubMed: 19183318] [CrossRef]
110.
Khunti K, Griffin S, Brennan A, Dallosso H, Davies MJ, Eborall HC, et al. Promoting physical activity in a multi-ethnic population at high risk of diabetes: the 48-month PROPELS randomised controlled trial. BMC Med 2021;19:130. [PMC free article: PMC8173914] [PubMed: 34078362]
111.
Brewer JT. Ethnography (Understanding Social Research). Philadelphia, PA: Open University Press; 2000.
112.
Wolfinger NH. On writing fieldnotes: collection strategies and background expectancies. Qual Res 2002;2:85–93. 10.1177/1468794102002001640 [CrossRef]
113.
Kwasnicka D, Dombrowski SU, White M, Sniehotta F. Theoretical explanations for maintenance of behaviour change: a systematic review of behaviour theories. Health Psychol Rev 2016;10:277–96. 10.1080/17437199.2016.1151372 [PMC free article: PMC4975085] [PubMed: 26854092] [CrossRef]
114.
Winkley K, Upsher R, Stahl D, Pollard D, Gillet M, Brennan A, Heller S, Ismail K. A systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in adults with Type 2 diabetes. Diabetic Med 2018;35:16–16. 10.2139/ssrn.3413604 [PMC free article: PMC7217004] [PubMed: 32022290] [CrossRef]
115.
Breeze P, Squires H, Chilcott J, Stride C, Diggle PJ, Brunner E, et al. A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study. J Public Health 2016;38:679–87. 10.1093/pubmed/fdv160 [PMC free article: PMC6092879] [PubMed: 28158533] [CrossRef]
116.
Thomas C, Sadler S, Breeze P, Squires H, Gillett M, Brennan A. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. BMJ Open 2017;7:e014953. 10.1136/bmjopen-2016-014953 [PMC free article: PMC5724090] [PubMed: 28827235] [CrossRef]
117.
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475–82. 10.1136/bmj.39609.449676.25 [PMC free article: PMC2440904] [PubMed: 18573856] [CrossRef]
118.
Curtis L, Burns A. Unit Costs of Health and Social Care 2016. Canterbury: Personal Social Services Research Unit, University of Kent; 2016.
119.
Regional Drug and Therapeutics Centre (RDTC) (Newcastle). Cost Comparisons Charts. Newcastle upon Tyne: RDTC; 2019.
120.
NHS Digital. Prescription Cost Analysis – England, 2018. Leeds: NHS Digital; 2018.
121.
Hernandez Alava M, et al. Methods for Mapping Between the EQ-5D-5L and the 3L for Technology Appraisal: Report by the Decision Support Unit. Sheffield: Decision Support Unit, ScHARR, University of Sheffield; 2017.
122.
van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. 10.1016/j.jval.2012.02.008 [PubMed: 22867780] [CrossRef]
123.
Henningsen A, Hamann J. Systemfit: a package for estimating systems of simultaneous equations. J Stat Software 2007;23:1–40. 10.18637/jss.v023.i04 [CrossRef]
124.
Rubin DB. Multiple Imputation for Nonresponse in Surveys. USA: John Wiley & Sons; 1987.
125.
Marmot M, Brunner E. Cohort profile: the Whitehall II study. Int J Epidemiol 2005;34:251–6. 10.1093/ije/dyh372 [PubMed: 15576467] [CrossRef]
126.
Rowlands A, Davies M, Dempsey P, Edwardson C, Razieh C, Yates T. Wrist-worn accelerometers: recommending ∼1.0 mg as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults. Br J Sports Med 2021;55:814–15. 10.1136/bjsports-2020-102293 [PubMed: 32928741] [CrossRef]
127.
US Department of Health and Human Services. Physical Activity Guidelines for Americans. 2nd edn. Washington, DC: US Department of Health and Human Services; 2018.
128.
Ki M, Pouliou T, Li L, Power C. Physical (in)activity over 20 y in adulthood: associations with adult lipid levels in the 1958 British birth cohort. Atherosclerosis 2011;219:361–7. 10.1016/j.atherosclerosis.2011.07.109 [PubMed: 21855876] [CrossRef]
129.
Liu J, Zeng FF, Liu ZM, Zhang CX, Ling WH, Chen YM. Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies. Lipids Health Dis 2013;12:159. 10.1186/1476-511X-12-159 [PMC free article: PMC4231478] [PubMed: 24164719] [CrossRef]
130.
Mok A, Khaw KT, Luben R, Wareham N, Brage S. Physical activity trajectories and mortality: population based cohort study. BMJ 2019;365:l2323. 10.1136/bmj.l2323 [PMC free article: PMC6592407] [PubMed: 31243014] [CrossRef]
131.
Davies MJ, Gray LJ, Troughton J, Gray A, Tuomilehto J, Farooqi A, et al. A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: The Let’s Prevent Diabetes cluster randomised controlled trial. Prev Med 2016;84:48–56. 10.1016/j.ypmed.2015.12.012 [PubMed: 26740346] [CrossRef]
132.
Harris T, Kerry SM, Limb ES, Furness C, Wahlich C, Victor CR, et al. Physical activity levels in adults and older adults 3-4 years after pedometer-based walking interventions: long-term follow-up of participants from two randomised controlled trials in UK primary care. PLOS Med 2018;15:e1002526. 10.1371/journal.pmed.1002526 [PMC free article: PMC5844512] [PubMed: 29522529] [CrossRef]
133.
Wyke S, Bunn C, Andersen E, Silva MN, van Nassau F, McSkimming P, et al. The effect of a programme to improve men’s sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial. PLOS Med 2019;16:e1002736. 10.1371/journal.pmed.1002736 [PMC free article: PMC6363143] [PubMed: 30721231] [CrossRef]
134.
Kinmonth AL, Wareham NJ, Hardeman W, Sutton S, Prevost AT, Fanshawe T, et al. Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial. Lancet 2008;371:41–8. 10.1016/S0140-6736(08)60070-7 [PubMed: 18177774] [CrossRef]
135.
Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. Lancet 2011;378:129–39. 10.1016/S0140-6736(11)60442-X [PubMed: 21705068] [CrossRef]
136.
Unick JL, Gaussoin SA, Hill JO, Jakicic JM, Bond DS, Hellgren M, et al. Four-year physical activity levels among intervention participants with type 2 diabetes. Med Sci Sports Exerc 2016;48:2437–45. 10.1249/MSS.0000000000001054 [PMC free article: PMC5110392] [PubMed: 27471785] [CrossRef]
137.
Elavsky S, Knapova L, Klocek A, Smahel D. Mobile health interventions for physical activity, sedentary behavior, and sleep in adults aged 50 years and older: a systematic literature review. J Aging Phys Act 2019;27:565–93. 10.1123/japa.2017-0410 [PubMed: 30507266] [CrossRef]
138.
Singh N, Stewart RAH, Benatar JR. Intensity and duration of lifestyle interventions for long-term weight loss and association with mortality: a meta-analysis of randomised trials. BMJ Open 2019;9:e029966. 10.1136/bmjopen-2019-029966 [PMC free article: PMC6701694] [PubMed: 31427335] [CrossRef]
139.
Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006;29:2102–7. 10.2337/dc06-0560 [PMC free article: PMC1762038] [PubMed: 16936160] [CrossRef]
140.
Uslan I, Acarturk G, Karaca E, Albayrak R, Yuksel S, Colbay M, et al. The effects of weight loss on normal transaminase levels in obese patients. Am J Med Sci 2007;334:327–30. 10.1097/MAJ.0b013e3181557702 [PubMed: 18004085] [CrossRef]
141.
Gc VS, Suhrcke M, Hardeman W, Sutton S, Wilson ECF, Very Brief Interventions Programme Team. Cost-effectiveness and value of information analysis of brief interventions to promote physical activity in primary care. Value Health 2018;21:18–26. 10.1016/j.jval.2017.07.005 [PubMed: 29304936] [CrossRef]
142.
Anokye N, Fox-Rushby J, Sanghera S, Cook DG, Limb E, Furness C, et al. Short-term and long-term cost-effectiveness of a pedometer-based exercise intervention in primary care: a within-trial analysis and beyond-trial modelling. BMJ Open 2018;8:e021978. 10.1136/bmjopen-2018-021978 [PMC free article: PMC6196874] [PubMed: 30337309] [CrossRef]
143.
Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, et al. Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK. Diabet Med 2017;34:1136–44. 10.1111/dme.13349 [PMC free article: PMC5573930] [PubMed: 28294392] [CrossRef]
144.
Leal J, Ahrabian D, Davies MJ, Gray LJ, Khunti J, Yates T, Gray AM. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let’s Prevent Diabetes cluster-randomised controlled trial. BMJ Open 2017;7:e013592. 10.1136/bmjopen-2016-013592 [PMC free article: PMC5223732] [PubMed: 28069625] [CrossRef]
145.
Sampson M, Elwell-Sutton T, Bachmann MO, Clark A, Dhatariya KK, Ferns C, et al. Discordance in glycemic categories and regression to normality at baseline in 10,000 people in a Type 2 diabetes prevention trial. Sci Rep 2018;8:6240. 10.1038/s41598-018-24662-y [PMC free article: PMC5908912] [PubMed: 29674706] [CrossRef]
146.
Mostafa SA, Khunti K, Srinivasan BT, Webb D, Gray LJ, Davies MJ. The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res Clin Pract 2010;90:100–8. 10.1016/j.diabres.2010.06.008 [PubMed: 20633944] [CrossRef]
147.
NHS England and NHS Improvement. Diabetes Prevention Programme Information Governance and Data Flows Framework. London: NHS England; 2016. URL: www​.england.nhs.uk/wp-content​/uploads/2019​/09/diabetes-prevention-programme-information-governance-and-data-flows-framework.pdf (accessed 17 November 2021).
148.
Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY pilot study. Am J Prev Med 2008;35:357–63. 10.1016/j.amepre.2008.06.035 [PMC free article: PMC2610485] [PubMed: 18779029] [CrossRef]
149.
Absetz P, Valve R, Oldenburg B, Heinonen H, Nissinen A, Fogelholm M, et al. Type 2 diabetes prevention in the ‘real world’: one-year results of the GOAL Implementation Trial. Diabetes Care 2007;30:2465–70. 10.2337/dc07-0171 [PubMed: 17586741] [CrossRef]
150.
Baumann S, Groß S, Voigt L, Ullrich A, Weymar F, Schwaneberg T, et al. Pitfalls in accelerometer-based measurement of physical activity: the presence of reactivity in an adult population. Scand J Med Sci Sports 2018;28:1056–63. 10.1111/sms.12977 [PubMed: 28921747] [CrossRef]
151.
Balducci S, D’Errico V, Haxhi J, Sacchetti M, Orlando G, Cardelli P, et al. Effect of a behavioral intervention strategy on sustained change in physical activity and sedentary behavior in patients with type 2 diabetes: the IDES_2 randomized clinical trial. JAMA 2019;321:880–90. 10.1001/jama.2019.0922 [PubMed: 30835309] [CrossRef]
Copyright © 2021 Khunti et al. This work was produced by Khunti et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
Bookshelf ID: NBK576328

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.6M)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...